Pneumococcal conjugate second or third-dose vaccines (PCVc) in Namibia
Namibia: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 83.0% in 2025. ◆ Volatile
Latest (2025)
83.0%
Change on year
up 9.2%
World rank
104th
of 194 countries
All-time high
85.0%
in 2022
All-time low
0.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Namibia, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Namibia recorded 83.0% for pneumococcal conjugate second or third-dose vaccines (pcvc) in 2025.
Compared with earlier readings it is up 9.2% on the previous year and up 2.5% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Namibia peaked at 85.0% in 2022 and was at its lowest, 0.0%, in 2008.
That places Namibia 104th out of 194 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Namibia, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 81.0% | — |
| 2016 | 84.0% | +3.7% |
| 2017 | 67.0% | -20.2% |
| 2018 | 61.0% | -9.0% |
| 2019 | 57.0% | -6.6% |
| 2020 | 78.0% | +36.8% |
| 2021 | 79.0% | +1.3% |
| 2022 | 85.0% | +7.6% |
| 2023 | 83.0% | -2.4% |
| 2024 | 76.0% | -8.4% |
| 2025 | 83.0% | +9.2% |
Namibia compared with similar countries
- Namibia's 83.0% is below the median for lower middle income countries, which is 84.0%, 99% of the median. (47 countries reporting)
- Namibia's 83.0% is above the median for Sub-Saharan Africa, which is 82.5%, 1.0× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 35.0% | 0.0% | 84.0% | 10 |
| 2020s | 80.7% | 76.0% | 85.0% | 6 |
Countries ranked near Namibia
More health data for Namibia
- Un projection of annual infant deaths, annual growth rate -1.75 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6445 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,046 deaths per 1,000 people (2090)
- Number of infants who die before age 1 561 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 1 (2024)
- Population ages 00-04, female, annual growth rate -1.83 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0644 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.56 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Namibia?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Namibia was 83.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Namibia?
- The highest recorded value was 85.0% in 2022.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Namibia?
- The lowest recorded value was 0.0% in 2008.
- How does Namibia rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Namibia ranks 104th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Namibia?
- Over the last ten years it is up 2.5%. The long-run trend across the full record is volatile.
- Where does this Namibia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).